BetterLife Pharma Inc. announced a non-brokered private placement of 2,200,000 units at a price of CAD 0.10 per non-brokered unit for aggregate gross proceeds of CAD 220,000 on July 13, 2023. Each non-brokered unit is comprised of one common share and one warrant. Each warrant entitles the holder thereof to acquire one common share at an exercise price of CAD 0.15 at any time up of 60 months from the closing of the offering.

The units sold pursuant to the offering will be subject to a four month hold period pursuant to applicable Canadian securities laws.